Mary K. Wloch

A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial

Mohamed A. Kharfan‐Dabaja, Michael Boeckh, Marissa B. Wilck et al. · The Lancet Infectious Diseases · 2012 · 229 citations · Full text

Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin

Larry Smith, Mary K. Wloch, Ming Ye et al. · Vaccine · 2010 · 141 citations

Vaccination, Cross-protection, Vaccine Development +9

Safety and Immunogenicity of a Bivalent Cytomegalovirus DNA Vaccine in Healthy Adult Subjects

Mary K. Wloch, Larry Smith, Souphaphone Boutsaboualoy et al. · The Journal of Infectious Diseases · 2008 · 139 citations · Full text

Vaxfectin enhances the humoral immune response to plasmid DNA-encoded antigens

Jukka Hartikka, Vesselina Bozoukova, Marilyn E. Ferrari et al. · Vaccine · 2001 · 97 citations

Vaccination, Host Response, Humoral Immune Response +6

A DNA-Based Vaccine for the Prevention of Human Cytomegalovirus-Associated Diseases

Cheryl Selinsky, Catherine J. Luke, Mary K. Wloch et al. · Human Vaccines · 2005 · 75 citations

Vaccination, Pp65 Pdnas, Allergy +15